Biomain AB, a leading provider of customized dental prosthetics in Scandinavia, has acquired Ostech AB, a Swedish distributor of dental implants and prosthetics. The combined company of Biomain and Ostech will further strengthen Biomain’s position on the Swedish dental prosthetics market.
Commenting on the acquisition, Joachim Samuelsson and Jerry Wiener, Board Directors at Biomain said: "This acquisition strengthens our position in the Scandinavian market as a leading provider of customized prosthetics. The synergies make us stronger and will accelerate our growth.”
“This is two companies with an attractive smart-buy offer that come together. There is an excellent fit with Biomain's market resources and product portfolio”, said Max Svenburg, Ostech’s CEO who will continue working in the Biomain group.
Ostech will be integrated into Biomain as quickly as possible to be able to operate under the common Biomain brand. Biomain’s new CEO Joakim Svensson said: “I very much welcome this acquisition and will work with the Ostech people to make the transition as smooth as possible for them and their customers.”
For further information please contact Biomain’s CEO Joakim Svensson at +46 42 453 07 00.
Biomain is an innovative dental company focussed on customized prosthetics. Biomain’s patented implant bridge I-Bridge2® with angulated screw channels is compatible with all leading implant systems. Biomain’s headquarter and modern production facility is located in Helsingborg, Sweden.